Home > Insider Trading > Filing (0001999371-24-002333)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1599298	Summit Therapeutics Inc.	SMMT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1963544	Yu Xia	C/O Summit Therapeutics Inc. 601 Brickell Key Drive, Suite 1000 Miami FL 33131		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-07	21,523,530	$1.05	21,523,530	No	4	P	Indirect	Akeso, Inc.
Common Stock	Acquisiton	2023-01-17	10,000,000	$2.51	10,000,000	No	4	P	Indirect	Akeso, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Akeso, Inc.
No	4	P	Indirect	Akeso, Inc.

Footnotes

21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering.
10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.("Akeso") pursuant to which the Issuer issued Akeso such shares.
Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest.